Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 4 versus week 8
Awards & highlights
Drug Has Already Been Approved
Pivotal Trial
Summary
This trial looks at using a CES device to reduce symptoms of anxiety over 8 weeks with 2 20-min sessions/day.
Eligible Conditions
- Anxiety
- Generalized Anxiety Disorder
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ week 4 versus week 8
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 4 versus week 8
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Secondary study objectives
Change in Beck Anxiety Inventory (BAI) Score
Change in Patient Health Questionnaire - 8 (PHQ-8)
Change in Promise Sleep-SD
+1 moreAwards & Highlights
Drug Has Already Been Approved
The FDA has already approved this drug, and is just seeking more data.
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Active ArmExperimental Treatment1 Intervention
Participants receive active device for the full 8 week study
Group II: Sham ArmPlacebo Group1 Intervention
Participants receive sham device for the first 4 weeks, and then at the week 5 cross over, receive the active device.
Find a Location
Who is running the clinical trial?
ProofPilotLead Sponsor
11 Previous Clinical Trials
1,556 Total Patients Enrolled
Fisher WallaceUNKNOWN
2 Previous Clinical Trials
375 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger